NARDON, Chiara
 Distribuzione geografica
Continente #
NA - Nord America 2.296
EU - Europa 1.945
AS - Asia 1.480
SA - Sud America 298
Continente sconosciuto - Info sul continente non disponibili 77
AF - Africa 55
OC - Oceania 10
Totale 6.161
Nazione #
US - Stati Uniti d'America 2.225
RU - Federazione Russa 919
SG - Singapore 644
CN - Cina 302
BR - Brasile 237
FR - Francia 213
IE - Irlanda 197
IT - Italia 163
VN - Vietnam 157
HK - Hong Kong 153
SE - Svezia 139
DE - Germania 116
GB - Regno Unito 80
KR - Corea 63
CA - Canada 43
FI - Finlandia 31
AR - Argentina 26
IN - India 26
BD - Bangladesh 22
ID - Indonesia 16
MX - Messico 16
JP - Giappone 15
PL - Polonia 15
ZA - Sudafrica 14
EC - Ecuador 13
BE - Belgio 12
IR - Iran 12
TR - Turchia 11
AT - Austria 10
ES - Italia 10
NL - Olanda 10
IQ - Iraq 9
AU - Australia 8
CO - Colombia 8
NG - Nigeria 8
LT - Lituania 7
TG - Togo 7
BJ - Benin 6
MA - Marocco 5
PK - Pakistan 5
UZ - Uzbekistan 5
AE - Emirati Arabi Uniti 4
CI - Costa d'Avorio 4
IL - Israele 4
MY - Malesia 4
PH - Filippine 4
PY - Paraguay 4
AL - Albania 3
CL - Cile 3
KG - Kirghizistan 3
PT - Portogallo 3
SA - Arabia Saudita 3
UA - Ucraina 3
VE - Venezuela 3
AZ - Azerbaigian 2
BG - Bulgaria 2
BO - Bolivia 2
CH - Svizzera 2
CR - Costa Rica 2
ET - Etiopia 2
GR - Grecia 2
GT - Guatemala 2
HN - Honduras 2
KE - Kenya 2
KW - Kuwait 2
NP - Nepal 2
OM - Oman 2
RO - Romania 2
SN - Senegal 2
AF - Afghanistan, Repubblica islamica di 1
AM - Armenia 1
AS - Samoa Americane 1
BW - Botswana 1
BY - Bielorussia 1
DO - Repubblica Dominicana 1
EE - Estonia 1
GA - Gabon 1
GE - Georgia 1
GM - Gambi 1
HU - Ungheria 1
JM - Giamaica 1
JO - Giordania 1
KH - Cambogia 1
KZ - Kazakistan 1
LB - Libano 1
LV - Lettonia 1
NC - Nuova Caledonia 1
NI - Nicaragua 1
NO - Norvegia 1
PA - Panama 1
PE - Perù 1
SK - Slovacchia (Repubblica Slovacca) 1
SL - Sierra Leone 1
SR - Suriname 1
SY - Repubblica araba siriana 1
TH - Thailandia 1
TJ - Tagikistan 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
VC - Saint Vincent e Grenadine 1
Totale 6.084
Città #
Dallas 391
Chandler 318
Moscow 296
Singapore 296
Ashburn 273
San Jose 236
Dublin 192
Hong Kong 152
Verona 101
Beijing 74
New York 73
Lawrence 60
Princeton 60
Ho Chi Minh City 55
Sindelfingen 51
Los Angeles 50
The Dalles 50
Kent 48
Munich 33
Buffalo 28
Hanoi 28
Southend 26
São Paulo 24
Orem 22
Redondo Beach 22
Santa Clara 20
Boardman 17
Council Bluffs 16
Montreal 16
San Francisco 16
Da Nang 15
Tokyo 15
Toronto 15
Chennai 14
Denver 13
Helsinki 12
Warsaw 12
Frankfurt am Main 11
Johannesburg 11
Brussels 10
Lappeenranta 10
London 10
Stockholm 10
Atlanta 9
Leawood 9
Sacramento 9
Turku 9
Belo Horizonte 8
Houston 8
West Jordan 8
Amsterdam 7
Brooklyn 7
Chicago 7
Jakarta 7
Lomé 7
Mexico City 7
Strasbourg 7
Campinas 6
Columbus 6
Cotonou 6
Lagos 6
Ninh Bình 6
Nuremberg 6
Poplar 6
São Bernardo do Campo 6
Thái Nguyên 6
Tianjin 6
Zanjan 6
Andover 5
Ankara 5
Barnet 5
Biên Hòa 5
Manchester 5
Meda 5
Phoenix 5
Romola 5
Tashkent 5
Abidjan 4
Baghdad 4
Buenos Aires 4
Curitiba 4
Dhaka 4
Falkenstein 4
Fortaleza 4
Guarulhos 4
Hải Dương 4
Milwaukee 4
Philadelphia 4
Quito 4
Rio de Janeiro 4
Salvador 4
Seattle 4
Thái Bình 4
Asunción 3
Augusta 3
Bishkek 3
Cambiago 3
Canberra 3
Caxias do Sul 3
Haiphong 3
Totale 3.507
Nome #
COMPOSTI DI COORDINAZIONE, SINTESI, NANOFORMULAZIONE ED USO DEGLI STESSI IN ONCOLOGIA (Ru, Ga) 191
COMPOSTI DI COORDINAZIONE, SINTESI, NANOFORMULAZIONE ED USO DEGLI STESSI IN ONCOLOGIA (Au, Cu) 170
“Composti di coordinazione, sintesi, nanoformulazione ed uso degli stessi come antinfiammatori” 165
An excellence in medicinal inorganic chemistry: a portrait of the gold(I/III) complexes patented for therapeutic purposes from 2010 to 2015 151
Ln(III) Complexes Embedded in Biocompatible PLGA Nanoparticles as Potential Vis-to-NIR Optical Probes 149
Near Infared Circularly Polarized Luminescence from water stable organic nanoparticles containing a chiral Yb(III) complex 146
Composti di coordinazione, sintesi, nanoformulazione ed uso degli stessi come antinfiammatori” n° domanda:102016000122377, brevetto per invenzione industriale (antiflogistic), 145
Beyond Platinums: Gold Complexes as Anticancer Agents 141
Circularly Polarized Luminescence from New Heteroleptic Eu(III) and Tb(III) Complexes 140
Cell and cell-free mechanistic studies on two gold(III) complexes with proved antitumor properties 131
Biological studies on Au(III) peptidomimetics about to enter Phase I clinical trials 130
Au(III)-Proline derivatives exhibiting selective antiproliferative activity against HepG2/SB3 apoptosis-resistant cancer cells 128
CuII and AuIII Complexes with Glycoconjugated Dithiocarbamato Ligands for Potential Applications in Targeted Chemotherapy 128
Synthesis, chemical characterization and cancer cell growth-inhibitory activities of Cu(ii) and Ru(iii) aliphatic and aromatic dithiocarbamato complexes 127
Cellular and Computational Studies of Proteasome Inhibition and Apoptosis Induction in Human Cancer Cells by Amino Acid Schiff Base-Copper Complexes 126
DESIGN AND DEVELOPMENT OF NEW METAL-BASED BIOSENSORS FOR THE EARLY DETECTION OF CANCER ANTIGENS IN ONCOLOGY 126
Copper(II)- and Ruthenium(III)-based complexes with promising anticancer activity 124
Editorial: Unravelling Copper-Regulatory Systems and Copper-Affected Pathways in Cancer Cells to Improve Current Therapies 121
20S proteasome inhibition by gold(III)-based antitumor agents: from in vitro and in vivo studies to X-ray crystallography 119
CCK8 peptide-labeled Pluronic® F127 micelles as a targeted vehicle of gold-based anticancer chemotherapeutics 116
CCK8 receptor-mediated cancer treatment strategies in target therapy 116
Anticancer Gold(III) Peptidomimetics: From Synthesis to in vitro and ex vivo Biological Evaluations 115
A new strategy in chemotherapy: preliminary studies on Cu(II) complexes aimed at exploiting the enhanced copper uptake in malignancies 114
New comprehensive studies of a gold(III) Dithiocarbamate complex with proven anticancer properties: Aqueous dissolution with cyclodextrins, pharmacokinetics and upstream inhibition of the ubiquitin-proteasome pathway 113
Cutting-Edge Nanosystems for Biomedical Applications 111
Cutting-edge anticancer agents: gold-based peptidomimetics targeting peptide transporters 109
Gold complexes for therapeutic purposes: An updated Patent review (2010-2015) 105
Novel inorganic chemotherapeutics for cancer treatment 100
Effect of the Heteroaromatic Antenna on the Binding of Chiral Eu(III) Complexes to Bovine Serum Albumin 98
Promising Anticancer Mono- and Dinuclear Ruthenium(III) Dithiocarbamato Complexes: Systematic Solution Studies 93
In vitro and in vivo anticancer activity of recently patented gold-based peptidomimetics targeting peptide transporters 91
NIR-emission from Yb(III)- and Nd(III)-based complexes in the solid state sensitized by a ligand system absorbing in a broad UV and visible spectral window 89
Target selective micelles for bombesin receptors incorporating Au(III)-dithiocarbamato complexes 88
Gold-based peptidomimetics for a targeted anticancer therapy 88
Design and development of new metal-based biosensors for the early detection of cancer antigens in oncology 84
Studio pilota sull’efficacia di una formulazione micellare contenente un complesso di Au(III) nel trattamento dell’artrite sperimentale da collagene nel topo 83
From cisplatin to world-shattering gold(III) anticancer agents 82
Lanthanide‐Based Complexes Containing a Chiral trans‐1,2‐Diaminocyclohexane (DACH) Backbone: Spectroscopic Properties and Potential Applications 80
Ubiquitin-Proteasome System impairment by the Gold(III) complex derivative AuL12 79
Noble metal-dithiocarbamates: precious allies in the fight against cancer 78
Design and Development of new metal-based biosensors for the early detection of cancer antigens in oncology 77
New metal-based cancer-targeting chemotherapeutics 75
Gold(III) complexes sensitize mitochondria of tumor cells to permeability transition 75
Throwing light on recent advances on metallodrugs: From deemed poisons to a striking hope for the future 71
Preclinical activity of multiple-target gold(III)-dithiocarbamato peptidomimetics in prostate cancer cells and xenografts 71
Toward the selective delivery of chemotherapeutics into tumor cells by targeting peptide transporters: tailored gold-based anticancer peptidomimetics 70
Enantioselective Cytotoxicity of Chiral Diphosphine Ruthenium(II) Complexes Against Cancer Cells 69
Gold(III)-pyrrolidinedithiocarbamato Derivatives as Antineoplastic Agents 69
New insights into the mechanism of action of the gold(III) dithiocarbamato complex AuL12: upstream inhibition of the ubiquitin-proteasome pathway and encapsulation in natural polysaccharides 69
New lanthanide-based biosensors for the early detection of cancer antigens 69
Selective delivery of chemotherapeutics into tumor cells by use of targeting peptides 66
Gold(III) Complexes in the Oncological Preclinical Arena: from Aminoderivatives to Peptidomimetics 65
Perspective gold(III)-dithiocarbamato anticancer therapeutics: learning from the past, moving to the future 65
Ru(III) anticancer agents with aromatic and non-aromatic dithiocarbamates as ligands: Loading into nanocarriers and preliminary biological studies 64
Targeting the ubiquitin-proteasome pathway with inorganic compounds to fight cancer: a challenge for the future 64
Gold(III) dithiocarbamate complexes induce cell death triggered by thioredoxin redox system inhibition, mitochondrial permeability increase, and activation of ERK pathway 63
Is matching ruthenium with dithiocarbamato ligands a potent chemotherapeutic weapon in oncology? 63
Metal-based dithiocarbamato anticancer agents: an overview 61
Gold(III)-Dithiocarbamato Peptidomimetics in the Forefront of the Targeted Anticancer Therapy: Preclinical Studies against Human Breast Neoplasia 60
Leading-edge gold(III) targeted chemotherapeutics in translational oncology 59
New metal-based cancer-targeting chemotherapeutics 58
Labelled micelles for the delivery of cytotoxic Cu(II) and Ru(III) compounds in the treatment of aggressive orphan cancers: design and biological in vitro data 51
Gold(III) to Ruthenium(III) Metal Exchange in Dithiocarbamato Complexes Tunes Their Biological Mode of Action for Cytotoxicity in Cancer Cells 13
Exploring the effect of copper on the bioactivity of 8-quinolines: an in vitro and in vivo study 4
Totale 6.161
Categoria #
all - tutte 25.448
article - articoli 14.179
book - libri 0
conference - conferenze 8.389
curatela - curatele 0
other - altro 0
patent - brevetti 2.102
selected - selezionate 0
volume - volumi 778
Totale 50.896


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022279 0 0 0 0 0 0 0 0 24 57 64 134
2022/2023967 87 117 90 177 54 242 1 55 116 5 13 10
2023/2024570 16 43 62 65 42 89 72 9 2 12 104 54
2024/20251.045 44 92 45 191 28 36 22 79 74 122 61 251
2025/20263.253 229 453 183 604 780 167 218 180 213 157 39 30
2026/202747 31 16 0 0 0 0 0 0 0 0 0 0
Totale 6.161